1. Rosenfield, RL, Ehrmann, DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev 2016; 37: 467–520.
Google Scholar | Crossref | Medline2. Sanchez-Garrido, MA, Tena-Sempere, M. Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab 2020; 35: 100937.
Google Scholar | Crossref | Medline3. Abraham Gnanadass, S, Divakar Prabhu, Y, Valsala Gopalakrishnan, A. Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update. Arch Gynecol Obstet 2021; 303: 631–643.
Google Scholar | Crossref | Medline4. Spritzer, PM, Lecke, SB, Satler, F, et al. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome. Reproduction 2015; 149: R219–R227.
Google Scholar | Crossref | Medline5. Eruzun, H, Toprak, İD, Arman, Y, et al. Serum endotrophin levels in patients with heart failure with reduced and mid-range ejection fraction. Eur J Intern Med 2019; 64: 29–32.
Google Scholar | Crossref | Medline6. Williams, L, Layton, T, Yang, N, et al. Collagen VI as a driver and disease biomarker in human fibrosis. FEBS J. Epub ahead of print 9 June 2021. DOI: 10.1111/febs.16039.
Google Scholar | Crossref7. Rostamtabar, M, Esmaeilzadeh, S, Tourani, M, et al. Pathophysiological roles of chronic low-grade inflammation mediators in polycystic ovary syndrome. J Cell Physiol 2021; 236: 824–838.
Google Scholar | Crossref | Medline8. Abdalla, MA, Deshmukh, H, Atkin, S, et al. A review of therapeutic options for managing the metabolic aspects of polycystic ovary syndrome. Ther Adv Endocrinol Metab 2020; 11: 2042018820938305.
Google Scholar | SAGE Journals9. Ghadge, AA, Khaire, AA, Kuvalekar, AA. Adiponectin: a potential therapeutic target for metabolic syndrome. Cytokine Growth Factor Rev 2018; 39: 151–158.
Google Scholar | Crossref | Medline10. Motta, G, Allasia, S, Ghigo, E, et al. Ghrelin actions on somatotropic and gonadotropic function in humans. Prog Mol Biol Transl Sci 2016; 138: 3–25.
Google Scholar | Crossref | Medline11. Glintborg, D, Andersen, M, Hagen, C, et al. Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls. Eur J Endocrinol 2006; 155: 337–345.
Google Scholar | Crossref | Medline12. Cardoso, NS, Ribeiro, VB, Dutra, SGV, et al. Polycystic ovary syndrome associated with increased adiposity interferes with serum levels of TNF-alpha and IL-6 differently from leptin and adiponectin. Arch Endocrinol Metab 2020; 64: 4–10.
Google Scholar | Crossref | Medline13. Waśko, R, Komarowska, H, Warenik-Szymankiewicz, A, et al. Elevated ghrelin plasma levels in patients with polycystic ovary syndrome. Horm Metab Res 2004; 36: 170–173.
Google Scholar | Crossref | Medline14. Ferriman, D, Gallwey, JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961; 21: 1440–1447.
Google Scholar | Crossref | Medline15. Stanczyk, FZ . Diagnosis of hyperandrogenism: biochemical criteria. Best Pract Res Clin Endocrinol Metab 2006; 20: 177–191.
Google Scholar | Crossref | Medline16. Sun, K, Park, J, Gupta, OT, et al. Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction. Nat Commun 2014; 5: 3485.
Google Scholar | Crossref | Medline17. Li, X, Zhao, Y, Chen, C, et al. Critical role of matrix metalloproteinase 14 in adipose tissue remodeling during obesity. Mol Cell Biol 2020; 40: e00564-19.
Google Scholar | Crossref18. Park, J, Scherer, PE. Adipocyte-derived endotrophin promotes malignant tumor progression. J Clin Invest 2012; 122: 4243–4256.
Google Scholar | Crossref | Medline19. Schiffer, L, Arlt, W, O’Reilly, MW. Understanding the role of androgen action in female adipose tissue. Front Horm Res 2019; 53: 33–49.
Google Scholar | Crossref | Medline20. Klöting, N, Blüher, M. Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord 2014; 15: 277–287.
Google Scholar | Crossref | Medline21. Moreira-Pais, A, Ferreira, R, Neves, JS, et al. Sex differences on adipose tissue remodeling: from molecular mechanisms to therapeutic interventions. J Mol Med 2020; 98: 483–493.
Google Scholar | Crossref | Medline22. Echiburú, B, Pérez-Bravo, F, Galgani, JE, et al. Enlarged adipocytes in subcutaneous adipose tissue associated to hyperandrogenism and visceral adipose tissue volume in women with polycystic ovary syndrome. Steroids 2018; 130: 15–21.
Google Scholar | Crossref | Medline23. Zheng, SH, Du, DF, Li, XL. Leptin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Reprod Sci 2017; 24: 656–670.
Google Scholar | SAGE Journals24. Svendsen, PF, Christiansen, M, Hedley, PL, et al. Adipose expression of adipocytokines in women with polycystic ovary syndrome. Fertil Steril 2012; 98: 235–241.
Google Scholar | Crossref | Medline25. O’Connor, A, Phelan, N, Tun, TK, et al. High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance. J Clin Endocrinol Metab 2010; 95: 1378–1385.
Google Scholar | Crossref | Medline26. Kim, M, Lee, C, Seo, DY, et al. The impact of endotrophin on the progression of chronic liver disease. Exp Mol Med 2020; 52: 1766–1776.
Google Scholar | Crossref | Medline27. Karsdal, MA, Henriksen, K, Genovese, F, et al. Serum endotrophin identifies optimal responders to PPARγ agonists in type 2 diabetes. Diabetologia 2017; 60: 50–59.
Google Scholar | Crossref | Medline28. Chait, A, den Hartigh, LJ. Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease. Front Cardiovasc Med 2020; 7: 22.
Google Scholar | Crossref | Medline29. Ożegowska, K, Bartkowiak-Wieczorek, J, Bogacz, A, et al. Relationship between adipocytokines and angiotensin converting enzyme gene insertion/deletion polymorphism in lean women with and without polycystic ovary syndrome. Gynecol Endocrinol 2020; 36: 496–500.
Google Scholar | Crossref | Medline30. Parida, S, Siddharth, S, Sharma, D. Adiponectin, obesity, and cancer: clash of the bigwigs in health and disease. Int J Mol Sci 2019; 20: 2519.
Google Scholar | Crossref31. Daghestani, MH, Daghestani, M, Daghistani, M, et al. A study of ghrelin and leptin levels and their relationship to metabolic profiles in obese and lean Saudi women with polycystic ovary syndrome (PCOS). Lipids Health Dis 2018; 17: 195.
Google Scholar | Crossref | Medline32. Kalyan, S, Goshtesabi, A, Sarray, S, et al. Assessing C reactive protein/albumin ratio as a new biomarker for polycystic ovary syndrome: a case-control study of women from Bahraini medical clinics. BMJ Open 2018; 8: e021860.
Google Scholar | Crossref | Medline33. Aydin Yoldemir, Ş, Arman, Y, Akarsu, M, et al. The relationship between insulin resistance, obesity, and endotrophin. Int J Diabetes Dev Ctries 2020; 40: 191–195.
Google Scholar | Crossref34. Khan, T, Muise, ES, Iyengar, P, et al. Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI. Mol Cell Biol 2009; 29: 1575–1591.
Google Scholar | Crossref | Medline35. Vendrell, J, Broch, M, Vilarrasa, N, et al. Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res 2004; 12: 962–971.
Google Scholar | Crossref | Medline